Alteration of signal-transducing molecules in tumor-infiltrating lymphocytes and peripheral blood T lymphocytes from human colorectal carcinoma patients

Cancer Immunology Immunotherapy

Volumn 45, Issue 6, 1998, Pages 299-305

  Choi, Sang Hoon ^a,d   Chung, Eun Joo ^a   Whang, Dae Yong ^b   Lee, Seung Sook ^b   Jang, Yong Suk ^c   Kim, Chul Woo ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Korea Cancer Center Hospital   (South Korea)

^c Chonbuk National University   (South Korea)

^d Kunsan National University   (South Korea)

Author keywords

Colorectal cancer; Immune suppression; Protein tyrosine kinase (PTK); TCR CD3; TIL

Indexed keywords

CD3 ANTIGEN; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR;

ADVANCED CANCER; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE;

EID: 15144339695     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050446     Document Type: Article

References (38)

1. Alexander J, Kudoh S, Melsop K, Hamilton T, Edinger M, Tubbs R, Sica D, Tuason L, Klein E, Bukowski R, Finke J (1993) T-cell infiltrating renal cell carcinoma display a poor proliferative response even though they can produce IL-2 and express IL-2 receptors. Cancer Res 53:1380
2. Aoe T, Okamoto Y, Saito T (1995) Activation macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J Exp Med 181: 1881
3. Azuma M, Phillips J, Lanier L (1993) CD28 T lymphocytes. J Immunol 150:1147
4. Blumberg R, Alarcon B, Sancho J, McDermott F, Lopez P, Breitmeyer J, Terhorst C (1990) Assembly and function of the T cell antigen receptor. J Biol Chem 265:14036
5. Boussiotis V, Barber D, Nakarai T, Freeman G, Gribben J, Bernstein G, D'Andrea A, Ritz J, Nadler L (1994) Prevention of T cell anergy by signaling through the γ chain of the IL-2 receptor. Nature 266:1039
6. Broder S, Waldmann T (1978) The suppressor-cell network in cancer. N Engl J Med 299:1281
7. + T lymphocytes in the primary and memory response to non-immunogenic murine mammary adenocarcinoma made immunogenic by the IL-2 gene. J Immunol 149:3627
8. Chan A, Iwashima M, Turck C, Weiss A (1992) ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell 71:649
9. lck association with CD4 is required for the interaction between CD4 and the TCR/CD3 complex and for optimal antigen stimulation. J Immunol 148:2159
10. Eiseman E, Bolen J (1990) src-related tyrosine protein kinases as signaling components in hematopoietic cells. Cancer Cells 2:303
11. Fearon E, Pardoll D, Itaya T, Golumbek P, Levitsky H, Simons J, Karasuyama H, Vogelstein B, Frost P (1990) Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60:397
12. lck in T cell infiltrating human renal-cell carcinoma. Cancer Res 53:5613
13. Hersh E, Oppenheim J (1965) Impaired in vitro lymphocyte transformation in Hodgkin's disease. N Engl J Med 273:1006
14. Hock H, Dorsch M, Kunzendorf U, Qin Z, Diamantstein T, Blankenstein T (1993) Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma. Proc Natl Acad Sci USA 90:2774
15. Itoh K, Tilden A, Balch C (1986) Interleukin-2 activation of cytotoxic T-lymphocytes infiltrating human metastatic melanomas. Cancer Res 46:3011
16. lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T cell line. Mol Cell Biol 12:4521
17. Lai P, Rabinowich H, Crowly-Nowik P, Bell M, Mantovani G, Whiteside T (1996) Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin Cancer Res 2:161
18. + T cells. J Immunol 149:949
19. Lombard G, Sidhu S, Batchelor R, Lechler R (1994) Anergic T cells as suppressor cells in vitro. Nature 264:1587
20. Malissen B, Schmitt-Verhulst A-M (1993) Transmembrane signalling through the T-cell-receptor-CD3 complex. Curr Opin Immunol 5:324
21. Matsuda M, Petersson M, Taupin J-L, Magnusson I, Mellstedt H, Lencei R, Anderson P, Kiessling R (1995) Alterations in the signal transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes; correlation with the stage of the disease. Int J Cancer 61:76525
22. Miescher S, Stoeck M, Quiao L, Barras C, Barrelet L, Von Fliedner V (1988) Proliferate and cytolytic potentials of purified human tumor-infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expression. Int J Cancer 42:659
23. Mizoguchi H, O'Shea J, Longo D, Loeffler C, McVicar D, Ochoa A (1992) Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258:1795
24. lck do not express significant antiviral effector functions. J Immunol 151:699
25. Mukherji B, MacAlister T (1983) Clonal analysis of cytotoxic T cell response against human melanoma. J Exp Med 158:240
26. Nakagomi H, Peterson M, Magnusson I, Juhlin C, Matuda M, Mellstedt H, Taupin J-L, Vivier E, Anderson P, Kiessling R (1993) Decreased expression of the signal-transducing zeta chain in tumor-infiltrating T cells and NK cells of patients with colorectal carcinoma. Cancer Res 53:5610
27. + helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2: an efficient strategy for adoptive tumor immunotherapy. J Immunol 148:285
28. O'Shea J, Weissman A, Kennedy I, Onalo J (1991) Engagement of the natural killer cell IgG Fc receptor results in tyrosine phosphorylation of the zeta chain. Proc Natl Acad Sci USA 88:350
29. lck with Fe¥ãRIIIa (CD16) in NK cells. J Exp Med 177:1475
30. Salvador S, Gansbacher B, Pizziment A, Zier K (1994) Abnormal signal transduction by T cells of mice with parental tumors is not seen in mice bearing IL-2 secreting tumors. J Immunol 153:5176
31. Samelson L, Phillips A, Luong E, Klausner, R (1990) Association of the fyn protein-tyrosine kinase with the T cell antigen receptor. Proc Natl Acad Sci USA 87:4358
32. Strauss D, Weiss A (1992) Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70:585
33. Sugie K, Kawakami T, Maeda Y, Kawabe T, Uchida A, Yodoi J (1991) fyn tyrosine kinase associated with Fe¥ãRII/CD23. Possible multiple roles in lymphocyte activation. Proc Natl Acad Sci USA 88:9132
34. Tartour E, Latour S, Mathiot C, Thiounn N, Mosseri V, Joyeux I, Dubois D'Enghien C, Lee R, Debre B, Fridman WH (1995) Variable expression of the CD3¥æ chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int J Cancer 63:205
35. Ting A, Einspahr K, Abraham R, Leibson P (1991) Fc gamma receptor signal transduction in natural killer cells: coupling to phospholipase C via a G protein-independent, but tyrosine kinase dependent pathway. J Immunol 147:3122
36. lck. Cell 55:301
37. Vivier E, Morin P, O'Brien C, Druker B, Schlossman S, Anderson P (1991) Tyrosine phosphorylation of the FcγRIII (CD16): complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. J Immunol 146:206
38. Zea A, Curti B, Longo D, Alvord W, Strobi S, Mizoguchi H, Creekmore S, O'Sea J, Powers G, Urba W, Ochoa A (1995) Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin Cancer Res 1:1327